Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Amortization of Deferred Charges: 2018-2021

Historic Amortization of Deferred Charges for EyePoint Pharmaceuticals (EYPT) over the last 4 years, with Dec 2021 value amounting to $628,000.

  • EyePoint Pharmaceuticals' Amortization of Deferred Charges rose 1276.47% to $600,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $843,000, marking a year-over-year change of. This contributed to the annual value of $628,000 for FY2021, which is 35.72% down from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Amortization of Deferred Charges of $628,000 as of FY2021, which was down 35.72% from $977,000 recorded in FY2020.
  • EyePoint Pharmaceuticals' Amortization of Deferred Charges' 5-year high stood at $1.1 million during FY2019, with a 5-year trough of $209,000 in FY2018.
  • Its 3-year average for Amortization of Deferred Charges is $885,667, with a median of $977,000 in 2020.
  • Data for EyePoint Pharmaceuticals' Amortization of Deferred Charges shows a maximum YoY slumped of 35.72% (in 2021) over the last 5 years.
  • EyePoint Pharmaceuticals' Amortization of Deferred Charges (Yearly) stood at $209,000 in 2018, then reached $1.1 million in 2019, then dropped by 7.13% to $977,000 in 2020, then plummeted by 35.72% to $628,000 in 2021.